​

Funding Round

Series C - Bigfoot Biomedical

Series C - Bigfoot Biomedical

Investment Firm

Overview

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.

Announced Date

Jan 13, 2020

Closed on Date

Jun 02, 2020

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Abbott

Abbott

No designation

Participant Investors

5

Investor Name
Participant InvestorQuadrant Capital Advisors
Participant InvestorSenvest Capital
Participant InvestorCormorant Asset Management
Participant InvestorSmile Group
Participant InvestorAbbott

Round Details and Background

Bigfoot Biomedical raised $55128488 on 2020-01-13 in Series C

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 15, 2022
Convertible Note - Bigfoot Biomedical
1-undefined
Jan 01, 2016
Seed Round - Bigfoot Biomedical
1-undefined
Oct 05, 2016
Series A - Bigfoot Biomedical
6-35.5M
Nov 18, 2014
Seed Round - Bigfoot Biomedical
2-2.0M

Recent Activity

There is no recent news or activity for this profile.